Seelos Therapeutics IncNASDAQ:SEELNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.8121
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.7933/ 1
- Ask / Lots0.8200/ 10
- Open / Previous Close0.7971 / 0.8121
- Day Range
- 52 Week Range
- Volume308,301
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SEEL |
|---|---|---|
| 09:32 ET | 9103 | 0.8123 |
| 09:33 ET | 700 | 0.797201 |
| 09:35 ET | 721 | 0.8047 |
| 09:39 ET | 185 | 0.8001 |
| 09:42 ET | 10992 | 0.791 |
| 09:44 ET | 100 | 0.791 |
| 09:55 ET | 500 | 0.7968 |
| 09:57 ET | 250 | 0.8025 |
| 10:00 ET | 2300 | 0.7926 |
| 10:02 ET | 1950 | 0.792 |
| 10:06 ET | 1500 | 0.8025 |
| 10:08 ET | 700 | 0.792 |
| 10:09 ET | 100 | 0.8025 |
| 10:11 ET | 800 | 0.7921 |
| 10:13 ET | 5600 | 0.7984 |
| 10:22 ET | 7642 | 0.8046 |
| 10:24 ET | 100 | 0.8042 |
| 10:27 ET | 4602 | 0.8049 |
| 10:29 ET | 500 | 0.8051 |
| 10:31 ET | 16090 | 0.8179 |
| 10:33 ET | 200 | 0.82 |
| 10:40 ET | 100 | 0.81 |
| 10:44 ET | 250 | 0.8281 |
| 10:45 ET | 100 | 0.8 |
| 10:47 ET | 800 | 0.82 |
| 10:49 ET | 500 | 0.8201 |
| 10:51 ET | 2696 | 0.82 |
| 10:54 ET | 1300 | 0.8002 |
| 10:58 ET | 301 | 0.8002 |
| 11:00 ET | 100 | 0.8 |
| 11:02 ET | 100 | 0.8 |
| 11:05 ET | 100 | 0.8 |
| 11:07 ET | 100 | 0.8 |
| 11:09 ET | 100 | 0.82 |
| 11:12 ET | 1400 | 0.82 |
| 11:14 ET | 100 | 0.8 |
| 11:16 ET | 100 | 0.82 |
| 11:20 ET | 200 | 0.82 |
| 11:23 ET | 200 | 0.8001 |
| 11:25 ET | 100 | 0.8 |
| 11:27 ET | 100 | 0.815 |
| 11:30 ET | 200 | 0.815 |
| 11:36 ET | 3900 | 0.8019 |
| 11:41 ET | 100 | 0.8007 |
| 11:45 ET | 250 | 0.8007 |
| 11:48 ET | 2960 | 0.8 |
| 11:50 ET | 2300 | 0.8 |
| 11:52 ET | 100 | 0.8 |
| 11:56 ET | 100 | 0.818 |
| 11:59 ET | 200 | 0.818 |
| 12:03 ET | 300 | 0.8101 |
| 12:08 ET | 1001 | 0.8101 |
| 12:12 ET | 279 | 0.8167 |
| 12:14 ET | 100 | 0.8101 |
| 12:15 ET | 1000 | 0.8101 |
| 12:17 ET | 100 | 0.8101 |
| 12:19 ET | 20400 | 0.8101 |
| 12:21 ET | 500 | 0.8101 |
| 12:24 ET | 100 | 0.8101 |
| 12:26 ET | 600 | 0.8101 |
| 12:30 ET | 2055 | 0.8101 |
| 12:33 ET | 400 | 0.8101 |
| 12:35 ET | 200 | 0.8148 |
| 12:39 ET | 100 | 0.8124 |
| 12:46 ET | 1465 | 0.810635 |
| 12:48 ET | 200 | 0.8101 |
| 12:50 ET | 200 | 0.8101 |
| 12:51 ET | 415 | 0.8147 |
| 12:55 ET | 500 | 0.8101 |
| 12:57 ET | 1606 | 0.808301 |
| 01:00 ET | 224 | 0.8115 |
| 01:06 ET | 239 | 0.8101 |
| 01:08 ET | 100 | 0.8101 |
| 01:11 ET | 200 | 0.81 |
| 01:13 ET | 200 | 0.8145 |
| 01:18 ET | 200 | 0.8145 |
| 01:20 ET | 100 | 0.8125 |
| 01:22 ET | 100 | 0.8125 |
| 01:24 ET | 1000 | 0.81 |
| 01:26 ET | 100 | 0.8097 |
| 01:27 ET | 100 | 0.8095 |
| 01:29 ET | 1300 | 0.8044 |
| 01:31 ET | 100 | 0.8097 |
| 01:36 ET | 415 | 0.815 |
| 01:38 ET | 548 | 0.8101 |
| 01:40 ET | 100 | 0.8101 |
| 01:42 ET | 533 | 0.815 |
| 01:44 ET | 1524 | 0.819 |
| 01:45 ET | 100 | 0.819 |
| 01:47 ET | 100 | 0.8051 |
| 01:49 ET | 300 | 0.8118 |
| 01:54 ET | 10399 | 0.8058 |
| 01:56 ET | 619 | 0.8 |
| 02:00 ET | 1382 | 0.8 |
| 02:03 ET | 10937 | 0.8103 |
| 02:09 ET | 343 | 0.8102 |
| 02:12 ET | 12572 | 0.796 |
| 02:14 ET | 400 | 0.796 |
| 02:16 ET | 2500 | 0.804 |
| 02:18 ET | 762 | 0.8096 |
| 02:21 ET | 100 | 0.8096 |
| 02:23 ET | 7500 | 0.805 |
| 02:25 ET | 1079 | 0.805 |
| 02:27 ET | 200 | 0.819 |
| 02:30 ET | 200 | 0.805 |
| 02:32 ET | 1100 | 0.8186 |
| 02:36 ET | 200 | 0.819 |
| 02:38 ET | 700 | 0.805 |
| 02:39 ET | 1800 | 0.8121 |
| 02:41 ET | 100 | 0.8182 |
| 02:43 ET | 100 | 0.8146 |
| 02:45 ET | 500 | 0.8146 |
| 02:48 ET | 100 | 0.8157 |
| 02:50 ET | 1700 | 0.8155 |
| 02:52 ET | 100 | 0.8146 |
| 02:56 ET | 780 | 0.8175 |
| 02:57 ET | 100 | 0.8146 |
| 02:59 ET | 1215 | 0.819 |
| 03:01 ET | 1473 | 0.81899 |
| 03:03 ET | 100 | 0.819 |
| 03:06 ET | 612 | 0.817908 |
| 03:10 ET | 1886 | 0.819 |
| 03:12 ET | 676 | 0.8103 |
| 03:14 ET | 35610 | 0.8 |
| 03:17 ET | 600 | 0.8197 |
| 03:19 ET | 100 | 0.8099 |
| 03:21 ET | 500 | 0.8099 |
| 03:24 ET | 158 | 0.8099 |
| 03:26 ET | 300 | 0.80995 |
| 03:28 ET | 500 | 0.8198 |
| 03:30 ET | 100 | 0.8101 |
| 03:32 ET | 200 | 0.8198 |
| 03:35 ET | 839 | 0.8158 |
| 03:37 ET | 1513 | 0.812 |
| 03:39 ET | 647 | 0.8119 |
| 03:42 ET | 100 | 0.8101 |
| 03:44 ET | 1631 | 0.8193 |
| 03:46 ET | 1029 | 0.8119 |
| 03:48 ET | 799 | 0.81 |
| 03:50 ET | 400 | 0.8 |
| 03:51 ET | 483 | 0.8186 |
| 03:53 ET | 1347 | 0.8119 |
| 03:55 ET | 38449 | 0.816 |
| 03:57 ET | 1802 | 0.8161 |
| 04:00 ET | 700 | 0.8121 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Seelos Therapeutics Inc | 87.0M | -1.0x | --- |
Bright Green Corp | 88.5M | -3.2x | --- |
Ocuphire Pharma Inc | 72.2M | -3.0x | --- |
I-Mab | 500.3M | -1.4x | --- |
Orchard Therapeutics PLC | 70.5M | -0.4x | --- |
PharmaCyte Biotech Inc | 54.1M | -10.7x | --- |
Company Information
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of products that address unmet needs in central nervous system (CNS) disorders and other rare disorders. The Company's lead programs SLS-002 for the treatment of acute suicidal ideation and behavior (ASIB) in depressive disorder (MDD), and SLS-005 for the potential treatment of amyotrophic lateral sclerosis (ALS). SLS-005 for the potential treatment of Sanfilippo Syndromes, which is being explored. It is also developing several preclinical programs, including SLS-010, an oral histamine H3A receptor antagonist that shows promising activity in narcolepsy and related disorders, and SLS-012, an injectable therapy for post-operative pain management. The Company's ongoing programs include SLS-004, SLS-006, SLS-007 and SLS-008.
Contact Information
- Headquarters
- 300 PARK AVENUE, 2ND FLOORNEW YORK, NY, United States 10022
- Phone
- 646-293-2100
- Fax
- 858-436-8155
Executives
- Chairman of the Board, President, Chief Executive Officer
- Raj Mehra
- Chief Financial Officer
- Michael Golembiewski
- Director
- Daniel O'Connor
- Independent Director
- Margaret Dalesandro
- Independent Director
- Brian Lian
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $87.0M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 107.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.03 |
EPS | $-0.78 |
Book Value | $0.54 |
P/E Ratio | -1.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
